$AUXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AUXILIUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AUXILIUM PHARMACEUTICALS INC. Get notifications about new insider transactions in AUXILIUM PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 22.04 | 30,000 | 661,200 | 149,460 | 119.5 K to 149.5 K (+25.11 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 25.90 | 75,000 | 1,942,500 | 119,460 | 44.5 K to 119.5 K (+168.69 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | M | 22.04 | 5,000 | 110,200 | 4,750 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | M | 19.51 | 28,500 | 556,035 | 28,500 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | M | 14.10 | 37,500 | 528,750 | 12,500 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 33.49 | 5,000 | 167,432 | 35,055 | 40.1 K to 35.1 K (-12.48 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 33.45 | 3,648 | 122,011 | 40,055 | 43.7 K to 40.1 K (-8.35 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 33.18 | 59,800 | 1,983,871 | 43,703 | 103.5 K to 43.7 K (-57.78 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 32.94 | 6,200 | 204,253 | 103,503 | 109.7 K to 103.5 K (-5.65 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Buy | M | 22.04 | 5,000 | 110,200 | 109,703 | 104.7 K to 109.7 K (+4.78 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Buy | M | 19.51 | 28,500 | 556,035 | 104,703 | 76.2 K to 104.7 K (+37.40 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Buy | M | 14.10 | 37,500 | 528,750 | 76,203 | 38.7 K to 76.2 K (+96.89 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | M | 18.30 | 9,375 | 171,563 | 28,125 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | M | 20.07 | 125,000 | 2,508,750 | 125,000 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Sell | S | 33.43 | 134,375 | 4,492,412 | 38,721 | 173.1 K to 38.7 K (-77.63 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Sell | S | 33.44 | 5,308 | 177,518 | 173,096 | 178.4 K to 173.1 K (-2.98 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Buy | M | 18.30 | 9,375 | 171,563 | 178,404 | 169 K to 178.4 K (+5.55 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Buy | M | 20.07 | 125,000 | 2,508,750 | 169,029 | 44 K to 169 K (+283.90 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 18.30 | 8,250 | 150,975 | 24,750 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 26.87 | 5,000 | 134,350 | 5,000 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 20.07 | 27,500 | 551,925 | 27,500 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Sell | S | 33.16 | 40,750 | 1,351,372 | 27,911 | 68.7 K to 27.9 K (-59.35 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Sell | S | 33.18 | 7,202 | 238,963 | 68,661 | 75.9 K to 68.7 K (-9.49 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 18.30 | 8,250 | 150,975 | 75,863 | 67.6 K to 75.9 K (+12.20 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 26.87 | 5,000 | 134,350 | 67,613 | 62.6 K to 67.6 K (+7.99 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 20.07 | 27,500 | 551,925 | 62,613 | 35.1 K to 62.6 K (+78.32 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 18.30 | 3,750 | 68,625 | 11,250 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 19.51 | 14,000 | 273,140 | 14,000 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 15.12 | 11,250 | 170,100 | 3,750 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 22.04 | 7,312 | 161,156 | 2,438 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 30.20 | 11,100 | 335,220 | 0 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | M | 31.85 | 22,000 | 700,700 | 0 | |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Sell | S | 33.50 | 69,412 | 2,325,031 | 14,874 | 84.3 K to 14.9 K (-82.35 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Sell | S | 33.50 | 6,391 | 214,075 | 84,286 | 90.7 K to 84.3 K (-7.05 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 18.30 | 3,750 | 68,625 | 90,677 | 86.9 K to 90.7 K (+4.31 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 19.51 | 14,000 | 273,140 | 86,927 | 72.9 K to 86.9 K (+19.20 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 15.12 | 11,250 | 170,100 | 72,927 | 61.7 K to 72.9 K (+18.24 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 22.04 | 7,312 | 161,156 | 61,677 | 54.4 K to 61.7 K (+13.45 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 30.20 | 11,100 | 335,220 | 54,365 | 43.3 K to 54.4 K (+25.66 %) |
Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Buy | M | 31.85 | 22,000 | 700,700 | 43,265 | 21.3 K to 43.3 K (+103.46 %) |
Oct 27 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 31.34 | 836 | 26,200 | 44,460 | 45.3 K to 44.5 K (-1.85 %) |
Oct 01 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 29.85 | 313 | 9,343 | 29,135 | 28.8 K to 29.1 K (+1.09 %) |
Aug 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Option Exercise | A | 17.51 | 165,000 | 2,889,150 | 165,000 | |
Aug 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jul 01 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 20.06 | 597 | 11,976 | 28,822 | 28.2 K to 28.8 K (+2.12 %) |
Jun 23 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 21.18 | 168 | 3,558 | 45,296 | 45.5 K to 45.3 K (-0.37 %) |
Jun 23 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 21.18 | 80 | 1,694 | 68,603 | 68.7 K to 68.6 K (-0.12 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Grant | A | 0.00 | 5,000 | 0 | 13,000 | 8 K to 13 K (+62.50 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 0.00 | 5,000 | 0 | 17,430 | 12.4 K to 17.4 K (+40.23 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 5,000 | 0 | 20,054 | 15.1 K to 20.1 K (+33.21 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 0.00 | 5,000 | 0 | 19,197 | 14.2 K to 19.2 K (+35.22 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 0.00 | 5,000 | 0 | 28,225 | 23.2 K to 28.2 K (+21.53 %) |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Option Exercise | A | 20.44 | 5,000 | 102,200 | 5,000 | |
May 22 2014 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Grant | A | 0.00 | 5,000 | 0 | 25,000 | 20 K to 25 K (+25.00 %) |
May 08 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Payment of Exercise | F | 20.82 | 305 | 6,350 | 17,819 | 18.1 K to 17.8 K (-1.68 %) |
Apr 01 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 27.18 | 288 | 7,828 | 23,225 | 22.9 K to 23.2 K (+1.26 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 17.59 | 883 | 15,532 | 2,692 | |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 13.16 | 20,625 | 271,425 | 0 | |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 9.15 | 10,000 | 91,500 | 0 | |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 29.55 | 524 | 15,484 | 5,798 | 6.3 K to 5.8 K (-8.29 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 29.55 | 883 | 26,093 | 6,322 | 7.2 K to 6.3 K (-12.26 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 17.59 | 883 | 15,532 | 7,205 | 6.3 K to 7.2 K (+13.97 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 29.50 | 30,625 | 903,438 | 22,735 | 53.4 K to 22.7 K (-57.39 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 13.16 | 20,625 | 271,425 | 53,360 | 32.7 K to 53.4 K (+63.01 %) |
Mar 17 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 9.15 | 10,000 | 91,500 | 32,735 | 22.7 K to 32.7 K (+43.99 %) |
Mar 06 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | M | 7.50 | 10,000 | 75,000 | 0 | |
Mar 06 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Sell | S | 31.85 | 10,000 | 318,477 | 22,937 | 32.9 K to 22.9 K (-30.36 %) |
Mar 06 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Buy | M | 7.50 | 10,000 | 75,000 | 32,937 | 22.9 K to 32.9 K (+43.60 %) |
Mar 04 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 30.75 | 2,500 | 76,875 | 2,500 | |
Mar 04 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 30.75 | 3,325 | 102,244 | 3,325 | |
Mar 04 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Payment of Exercise | F | 30.75 | 175 | 5,381 | 6,322 | 6.5 K to 6.3 K (-2.69 %) |
Mar 04 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 1,000 | 0 | 6,497 | 5.5 K to 6.5 K (+18.19 %) |
Mar 04 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 1,300 | 0 | 5,497 | 4.2 K to 5.5 K (+30.97 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 28.30 | 35,000 | 990,500 | 35,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 14,500 | 0 | 45,464 | 31 K to 45.5 K (+46.83 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 28.30 | 704 | 19,923 | 30,964 | 31.7 K to 31 K (-2.22 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 6,375 | 0 | 31,668 | 25.3 K to 31.7 K (+25.20 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 28.30 | 35,000 | 990,500 | 35,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 14,500 | 0 | 38,205 | 23.7 K to 38.2 K (+61.17 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Payment of Exercise | F | 28.30 | 704 | 19,923 | 23,705 | 24.4 K to 23.7 K (-2.88 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 6,375 | 0 | 24,409 | 18 K to 24.4 K (+35.35 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Option Exercise | A | 28.30 | 40,600 | 1,148,980 | 40,600 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Grant | A | 0.00 | 16,300 | 0 | 44,029 | 27.7 K to 44 K (+58.78 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Payment of Exercise | F | 28.30 | 623 | 17,631 | 27,729 | 28.4 K to 27.7 K (-2.20 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Grant | A | 0.00 | 6,375 | 0 | 28,352 | 22 K to 28.4 K (+29.01 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Option Exercise | A | 0.00 | 9,200 | 0 | 9,200 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Option Exercise | A | 28.30 | 13,700 | 387,710 | 13,700 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Grant | A | 0.00 | 5,500 | 0 | 18,124 | 12.6 K to 18.1 K (+43.57 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Payment of Exercise | F | 28.30 | 535 | 15,141 | 12,624 | 13.2 K to 12.6 K (-4.07 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Grant | A | 0.00 | 4,875 | 0 | 13,159 | 8.3 K to 13.2 K (+58.85 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 28.30 | 31,200 | 882,960 | 31,200 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 12,500 | 0 | 35,113 | 22.6 K to 35.1 K (+55.28 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 28.30 | 704 | 19,923 | 22,613 | 23.3 K to 22.6 K (-3.02 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 6,375 | 0 | 23,317 | 16.9 K to 23.3 K (+37.63 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 28.30 | 37,000 | 1,047,100 | 37,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 63,683 | 48.7 K to 63.7 K (+30.81 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 28.30 | 668 | 18,904 | 48,683 | 49.4 K to 48.7 K (-1.35 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 6,375 | 0 | 49,351 | 43 K to 49.4 K (+14.83 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 0.00 | 9,200 | 0 | 9,200 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 28.30 | 13,700 | 387,710 | 13,700 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 5,500 | 0 | 22,735 | 17.2 K to 22.7 K (+31.91 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Payment of Exercise | F | 28.30 | 495 | 14,009 | 17,235 | 17.7 K to 17.2 K (-2.79 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Grant | A | 0.00 | 4,875 | 0 | 17,730 | 12.9 K to 17.7 K (+37.92 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | A | 0.00 | 9,200 | 0 | 9,200 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Option Exercise | A | 28.30 | 15,750 | 445,725 | 15,750 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Grant | A | 0.00 | 6,350 | 0 | 21,265 | 14.9 K to 21.3 K (+42.57 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Armstrong Jennifer Lou | Senior Vice Preside ... | Grant | A | 0.00 | 4,875 | 0 | 14,915 | 10 K to 14.9 K (+48.56 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Option Exercise | A | 0.00 | 58,000 | 0 | 58,000 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Option Exercise | A | 28.30 | 156,500 | 4,428,950 | 156,500 | |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Grant | A | 0.00 | 62,500 | 0 | 217,778 | 155.3 K to 217.8 K (+40.25 %) |
Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | ADAMS ADRIAN | CEO and President | Grant | A | 0.00 | 23,775 | 0 | 155,278 | 131.5 K to 155.3 K (+18.08 %) |
Feb 19 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Payment of Exercise | F | 26.80 | 108 | 2,894 | 18,034 | 18.1 K to 18 K (-0.60 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | JOBES ELIZABETH VARKI | Chief Compliance Of ... | Payment of Exercise | F | 23.68 | 716 | 16,955 | 8,284 | 9 K to 8.3 K (-7.96 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | KOVEN ANDREW I | EVP, CAO, GC and Se ... | Payment of Exercise | F | 23.68 | 911 | 21,572 | 21,977 | 22.9 K to 22 K (-3.98 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | Tursi James Patrick | Chief Medical Offic ... | Payment of Exercise | F | 23.68 | 2,043 | 48,378 | 18,142 | 20.2 K to 18.1 K (-10.12 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 23.68 | 2,269 | 53,730 | 25,293 | 27.6 K to 25.3 K (-8.23 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 23.68 | 1,986 | 47,028 | 16,942 | 18.9 K to 16.9 K (-10.49 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 23.68 | 2,156 | 51,054 | 42,976 | 45.1 K to 43 K (-4.78 %) |
Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Payment of Exercise | F | 23.68 | 1,069 | 25,314 | 12,855 | 13.9 K to 12.9 K (-7.68 %) |
Feb 04 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 24.70 | 388 | 9,584 | 18,928 | 19.3 K to 18.9 K (-2.01 %) |
Jan 14 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Buy | J | 0.00 | 2,454 | 0 | 15,054 | 12.6 K to 15.1 K (+19.48 %) |
Jan 14 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Sell | J | 0.00 | 1,227 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
Jan 14 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Sell | J | 0.00 | 1,227 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
Jan 02 2014 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 20.73 | 361 | 7,484 | 12,600 | 12.2 K to 12.6 K (+2.95 %) |
Jan 02 2014 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 20.73 | 361 | 7,484 | 22,937 | 22.6 K to 22.9 K (+1.60 %) |
Dec 16 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 13.16 | 4,300 | 56,588 | 0 | |
Dec 16 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 20.50 | 302 | 6,191 | 4,064 | 4.4 K to 4.1 K (-6.92 %) |
Dec 16 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 20.50 | 4,300 | 88,150 | 4,366 | 8.7 K to 4.4 K (-49.62 %) |
Dec 16 2013 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 13.16 | 4,300 | 56,588 | 8,666 | 4.4 K to 8.7 K (+98.49 %) |
Dec 12 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 71,067 | 339,700 | 0 | |
Dec 12 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 20.37 | 71,067 | 1,447,450 | 45,132 | 116.2 K to 45.1 K (-61.16 %) |
Dec 12 2013 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 71,067 | 339,700 | 116,199 | 45.1 K to 116.2 K (+157.46 %) |
Oct 29 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 17.27 | 813 | 14,041 | 27,562 | 28.4 K to 27.6 K (-2.87 %) |
Oct 01 2013 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 18.20 | 411 | 7,480 | 12,239 | 11.8 K to 12.2 K (+3.47 %) |
Oct 01 2013 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 18.20 | 411 | 7,480 | 22,576 | 22.2 K to 22.6 K (+1.85 %) |
Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.81 | 31 | 583 | 14,197 | 14.2 K to 14.2 K (-0.22 %) |
Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.78 | 200 | 3,756 | 14,228 | 14.4 K to 14.2 K (-1.39 %) |
Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.77 | 200 | 3,754 | 14,428 | 14.6 K to 14.4 K (-1.37 %) |
Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.76 | 500 | 9,380 | 14,628 | 15.1 K to 14.6 K (-3.31 %) |
Aug 15 2013 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Sell | S | 18.75 | 300 | 5,625 | 15,128 | 15.4 K to 15.1 K (-1.94 %) |